Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.

Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Csomor E, Sellman BR, Mustelin T, Sleeman MA, de Bruin-Weller MS, Herath A, Drylewicz J, May RD, Hijnen D.

J Allergy Clin Immunol. 2017 Apr 13. pii: S0091-6749(17)30583-3. doi: 10.1016/j.jaci.2017.03.023. [Epub ahead of print]

PMID:
28412391
2.

Candidate serum markers in early Crohn's disease: predictors of disease course.

Smids C Md, Horjus Talabur Horje CS Md PhD, Nierkens S PhD, Drylewicz J PhD, Groenen MJ Md PhD, Wahab PJ Md PhD, van Lochem EG PhD.

J Crohns Colitis. 2017 Mar 27. doi: 10.1093/ecco-jcc/jjx049. [Epub ahead of print]

PMID:
28369318
3.

Reduced number of relapses of human leucocyte antigen-B27-associated uveitis during pregnancy.

Verhagen FH, Braakenburg AM, Kremer T, Drylewicz J, Rothova A, de Boer JH.

Acta Ophthalmol. 2017 Mar 7. doi: 10.1111/aos.13387. [Epub ahead of print] No abstract available.

PMID:
28266797
4.

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.

Drylewicz J, Schellens IM, Gaiser R, Nanlohy NM, Quakkelaar ED, Otten H, van Dorp S, Jacobi R, Ran L, Spijkers S, Koning D, Schuurman R, Meijer E, Pietersma FL, Kuball J, van Baarle D.

J Transl Med. 2016 Aug 2;14(1):230. doi: 10.1186/s12967-016-0988-4.

5.

Maraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot Study.

Krikke M, Tesselaar K, Arends JE, Drylewicz J, Otto SA, van Lelyveld SF, Visseren FJ, Hoepelman AI.

Infect Dis Ther. 2016 Sep;5(3):389-404. doi: 10.1007/s40121-016-0115-0. Epub 2016 Jun 14.

6.

Reconciling Longitudinal Naive T-Cell and TREC Dynamics during HIV-1 Infection.

Drylewicz J, Vrisekoop N, Mugwagwa T, de Boer AB, Otto SA, Hazenberg MD, Tesselaar K, de Boer RJ, Borghans JA.

PLoS One. 2016 Mar 24;11(3):e0152513. doi: 10.1371/journal.pone.0152513. eCollection 2016.

7.

Reconciling Estimates of Cell Proliferation from Stable Isotope Labeling Experiments.

Ahmed R, Westera L, Drylewicz J, Elemans M, Zhang Y, Kelly E, Reljic R, Tesselaar K, de Boer RJ, Macallan DC, Borghans JA, Asquith B.

PLoS Comput Biol. 2015 Oct 5;11(10):e1004355. doi: 10.1371/journal.pcbi.1004355. eCollection 2015 Oct.

8.

Quantification of naive and memory T-cell turnover during HIV-1 infection.

Vrisekoop N, Drylewicz J, Van Gent R, Mugwagwa T, Van Lelyveld SF, Veel E, Otto SA, Ackermans MT, Vermeulen JN, Huidekoper HH, Prins JM, Miedema F, de Boer RJ, Tesselaar K, Borghans JA.

AIDS. 2015 Oct 23;29(16):2071-80. doi: 10.1097/QAD.0000000000000822.

PMID:
26213901
9.

Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.

van Lelyveld SF, Drylewicz J, Krikke M, Veel EM, Otto SA, Richter C, Soetekouw R, Prins JM, Brinkman K, Mulder JW, Kroon F, Middel A, Symons J, Wensing AM, Nijhuis M, Borghans JA, Tesselaar K, Hoepelman AI; MIRS study group..

PLoS One. 2015 Jul 24;10(7):e0132430. doi: 10.1371/journal.pone.0132430. eCollection 2015.

10.

Lymphocyte maintenance during healthy aging requires no substantial alterations in cellular turnover.

Westera L, van Hoeven V, Drylewicz J, Spierenburg G, van Velzen JF, de Boer RJ, Tesselaar K, Borghans JA.

Aging Cell. 2015 Apr;14(2):219-27. doi: 10.1111/acel.12311. Epub 2015 Jan 28.

11.

Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection.

Thiébaut R, Drylewicz J, Prague M, Lacabaratz C, Beq S, Jarne A, Croughs T, Sekaly RP, Lederman MM, Sereti I, Commenges D, Lévy Y.

PLoS Comput Biol. 2014 May 22;10(5):e1003630. doi: 10.1371/journal.pcbi.1003630. eCollection 2014 May.

12.

Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans.

Westera L, Drylewicz J, den Braber I, Mugwagwa T, van der Maas I, Kwast L, Volman T, van de Weg-Schrijver EH, Bartha I, Spierenburg G, Gaiser K, Ackermans MT, Asquith B, de Boer RJ, Tesselaar K, Borghans JA.

Blood. 2013 Sep 26;122(13):2205-12. doi: 10.1182/blood-2013-03-488411. Epub 2013 Aug 14.

13.

NIMROD: a program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations.

Prague M, Commenges D, Guedj J, Drylewicz J, Thiébaut R.

Comput Methods Programs Biomed. 2013 Aug;111(2):447-58. doi: 10.1016/j.cmpb.2013.04.014. Epub 2013 Jun 10. Erratum in: Comput Methods Programs Biomed. 2014 Mar;113(3):927.

PMID:
23764196
14.

Treatment monitoring of HIV-infected patients based on mechanistic models.

Prague M, Commenges D, Drylewicz J, Thiébaut R.

Biometrics. 2012 Sep;68(3):902-11. doi: 10.1111/j.1541-0420.2012.01749.x. Epub 2012 Aug 30.

PMID:
22934714
15.

First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.

Drylewicz J, Eholie S, Maiga M, Zannou DM, Sow PS, Ekouevi DK, Peterson K, Bissagnene E, Dabis F, Thiébaut R; International epidemiologic Databases to Evaluate AIDS (IeDEA) West Africa Collaboration..

AIDS. 2010 Apr 24;24(7):1043-50.

16.

Score tests for exploring complex models: application to HIV dynamics models.

Drylewicz J, Commenges D, Thiébaut R.

Biom J. 2010 Feb;52(1):10-21. doi: 10.1002/bimj.200900030.

PMID:
19937998
17.

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.

Drylewicz J, Matheron S, Lazaro E, Damond F, Bonnet F, Simon F, Dabis F, Brun-Vezinet F, Chêne G, Thiébaut R.

AIDS. 2008 Feb 19;22(4):457-68. doi: 10.1097/QAD.0b013e3282f4ddfc.

Supplemental Content

Loading ...
Support Center